Core Insights - FibroBiologics, Inc. is a clinical-stage biotechnology company focused on developing therapeutics for chronic diseases using fibroblast technology, holding over 275 patents [1][6] - The company will present its recent research on fibroblast-based technology for wound healing and psoriasis at the Advanced Wound Care Summit on July 15, 2025 [1][2] Company Overview - FibroBiologics is based in Houston and is developing a pipeline of treatments aimed at chronic diseases, including diabetic foot ulcers, multiple sclerosis, and cancer [6] - The company emphasizes a novel approach to treatment that leverages the body's natural regenerative processes rather than merely managing symptoms [2][6] Upcoming Events - The Advanced Wound Care Summit will take place from July 15 to 17, 2025, in Boston, featuring global leaders in wound care innovation and clinical research [3] - The presentation by CEO Pete O'Heeron is scheduled for July 15, 2025, at 2 p.m. ET at the Marriott Courtyard Boston Downtown [3]
FibroBiologics to Present at the Advanced Wound Care Summit USA